Head To Head Top Stocks: Laredo Petroleum, Inc. (NYSE:LPI), Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

earning reaction history

Laredo Petroleum, Inc. (NYSE:LPI)

Laredo Petroleum, Inc. (NYSE:LPI) closed at $2.7 on the last trading session with an decrease of -2.17%, whereas, it previously closed at $2.76. The company has a market capitalization of $638.79 Million. The company traded shares of 3.28 Million on the trading day while its three month average volume stands at 6.24 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Laredo Petroleum, Inc. (NYSE:LPI) produced diluted EPS of 1.6. The EPS estimate for next year as estimated by analysts is at 0.84 while EPS for next quarter is estimated at 0.18. Earnings per Share growth for this year is reported at -39.1, while the analysts estimated the EPS growth for next year at 0.84% and Earnings growth for next 5 years stands at -4.63% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 9.9%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Laredo Petroleum, Inc. (NYSE:LPI) is at 1.69 while the forward p/e is at 3.2. The P/S or Price to Sales ratio of Laredo Petroleum, Inc. (NYSE:LPI) stands at 0.69 and Price to Book or P/B for the most recent quarter stands at 0.46. The Price to Free Cash Flow ratio or P/FCF is reported at 1.2. The quick ratio and the current ratio of Laredo Petroleum, Inc. (NYSE:LPI) are reported at 0 and 1.1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Laredo Petroleum, Inc. (NYSE:LPI) stands at 14.9, 31.3 and 16 respectively

The trailing twelve month Revenue of Laredo Petroleum, Inc. (NYSE:LPI) is reported at 920.6 Million with income of 368.5 Million. The outstanding shares of Laredo Petroleum, Inc. (NYSE:LPI) are 236.59 Million. The institutional Ownership of the shares of 98.5 stands at 0.80%, this figure is decreased -1.36 in the last six months. The insider ownership for the shares of Laredo Petroleum, Inc. (NYSE:LPI) is ticked at 1.3%, the figure is plummeted -2.22% in the last six months.

Some other important financial aspects to be discussed here for Laredo Petroleum, Inc. (NYSE:LPI) is the Mean Target Price estimated by the analysts which stands at 4.52. The 52 week high of Laredo Petroleum, Inc. (NYSE:LPI) is placed at 9.03 and 52 week low is standing at 2.26.

Performance wise the shares of Laredo Petroleum, Inc. (NYSE:LPI) fell down -1.46% for the week, it also fell -7.53% for the monthly performance, while for the quarter it went down 6.3%. The shares decrease -17.68% for the half year and plummeted for the Year-To-Date performance. The shares of Laredo Petroleum, Inc. (NYSE:LPI) shrinked -67.55% for the yearly performance.

Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) closed at $101.12 on the last trading session with an decrease of -0.29%, whereas, it previously closed at $101.41. The company has a market capitalization of $9.24 Billion. The company traded shares of 776695 on the trading day while its three month average volume stands at 661.78 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) produced diluted EPS of 0.13. The EPS estimate for next year as estimated by analysts is at 3.52 while EPS for next quarter is estimated at 0.63. Earnings per Share growth for this year is reported at 113.7, while the analysts estimated the EPS growth for next year at 3.52% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 18.3%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is at 760.3 while the forward p/e is at 28.73. The P/S or Price to Sales ratio of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stands at 15.27 and Price to Book or P/B for the most recent quarter stands at 19.12. The Price to Free Cash Flow ratio or P/FCF is reported at 209.08. The quick ratio and the current ratio of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) are reported at 7.3 and 7.4 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stands at 1.8, 4 and 4.2 respectively

The trailing twelve month Revenue of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is reported at 605.2 Million with income of 18.1 Million. The outstanding shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) are 91.39 Million. The institutional Ownership of the shares of 0 stands at 0.80%, this figure is increased 1.58 in the last six months. The insider ownership for the shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is ticked at 1%, the figure is plummeted -31.88% in the last six months.

Some other important financial aspects to be discussed here for Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is the Mean Target Price estimated by the analysts which stands at 111.33. The 52 week high of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is placed at 125.59 and 52 week low is standing at 64.72.

Performance wise the shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) rose up 5.98% for the week, it also rise 2.43% for the monthly performance, while for the quarter it went down 18.38%. The shares increase 19.2% for the half year and flew up for the Year-To-Date performance. The shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) shrinked -13.84% for the yearly performance.